Recurrence in childhood medulloblastoma

Journal of Neuro-Oncology

Volumn 103, Issue 3, 2011, Pages 705-711

  Warmuth Metz, Monika ^a   Blashofer, Sophia ^a   Von Bueren, André O ^d   Von Hoff, Katja ^d   Bison, Brigitte ^a   Pohl, Fabian ^a   Kortmann, Rolf Dieter ^b   Pietsch, Torsten ^c   Rutkowski, Stefan ^d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Medulloblastoma; Meningeal dissemination; Relapse

Indexed keywords

METHOTREXATE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MALE; MEDULLOBLASTOMA; MENINGEAL METASTASIS; OVERALL SURVIVAL; PRESCHOOL CHILD; SURGICAL TECHNIQUE; THERAPY DELAY;

CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDULLOBLASTOMA; MENINGES; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79959788925     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0452-x     Document Type: Article

References (24)

1. Kaatsch P, Rickert CH, Kühl J, Schüz J, Michaelis J (2001) Population-based epidemiologic data on brain tumours in German children. Cancer 92:3155-3164 (Pubitemid 33136212)
2. Packer RJ, Rood BR, MacDonald TJ (2003) Medulloblastoma: present concepts of stratification into risk groups. Pediatr Neurosurg 39:60-67 (Pubitemid 36829097)
3. Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, Wisoff JH, Geyer JR, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17:832-845 (Pubitemid 29109313)
4. Kortmann RD, Kühl J, Timmermann B, Mittler U, Urban C, Budach V, Richter E, Willich N, Flentje M, Berthold F, Slavc I, Wolff J, Meisner C, Wiestler O, Soerensen N, Warmuth-Metz M, Bamberg M (2000) Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT'91. Int J Radiat Oncol Biol Phys 46:269-279 (Pubitemid 30067775)
5. Inakoshi H, Kayamori R, Tsuchida E, Sakai K, Shibamoto Y, Wakushima H, Ogawa J, Kobayashi M, Obara T (2003) Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation. Radiat Med 2:37-45 (Pubitemid 36368152)
6. Bouffet E, Doz F, Demaille MC, Tron P, Roche H, Plantaz D, Thyss A, Stephan JL, Lejars O, Sariban E, Buclon M, Zücker JM, Brunat-Mentigny M, Bernard JL, Gentet JC (1998) Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse? Br J Cancer 77:1321-1326
7. Sure U, Bertalanffy H, Isenmann S, Brandner S, Berghorn WJ, Seeger W, Aguzzi A (1995) Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients. Acta Neurochir 136:117-126
8. Rutkowski S, von Bueren AO, Warmuth-Metz M, Soerensen N, Deinlein F, Schlegel PG, Kühl J, Benesch M, Zwiener I, Faldum A, Pietsch T, Kortmann RD (2010) Treatment of children and adolescents with metastatic medulloblastoma by conventional chemotherapy and hyperfractionated radiotherapy. Preliminary results of the prospective GPOH-trial HIT 2000 (MET HIT 2000 AB4). Neuro Oncol 12:ii5 (abstr)
9. Von Hoff K, Hinkes B, Gerber N, Deinlein F, Mittler U, Urban C, Benesch M, Warmuth-Metz M, Soerensen N, Zwiener I, Goette H, Schlegel PG, Pietsch T, Kortmann RD, Kuehl J, Rutkowski S (2009) Long-term outcome and clinical prognostic factors in children with medulloblastomas treated in the prospective randomised multicentre trial HIT'91. Eur J Cancer 45:1209-1217
10. Lannering B, Rutkowski S, Doz F, Pizer B, Gustafson G, Navajas A, Massimino M, Faldum A, Clifford S, Pietsch T, Kortmann R-D (2010) HIT-SIOP PNET4. A randomised multicentre study of hyperfractionated (HFRT) versus standard radiotherapy (StRT) in children with standard risk medulloblastoma. Neuro Oncol 12:ii5 (abstr)
11. Von Bueren AO, Pietsch T, Warmuth-Metz M, Soerensen N, Deinlein F, Schlegel PG, Kühl J, Benesch M, Zwiener I, Faldum A, Kortmann RD, Rutkowski S (2010) Treatment of young children (<4 years) with medulloblastoma by chemotherapy alone. Interim results of the prospective multicenter GPOH-trial HIT 2000 (HIT 2000 BIS4) confirming the prognostic impact of histology. Neuro Oncol 12:ii7 (abstr)
12. Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, Kortmann RD, Kühl J (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352:978-986 (Pubitemid 40349500)
13. Di Rocco C, Iannelli A, Tancredi A (1995) Patterns of failure in surgical therapy of medulloblastomas. J Neurosurg Sci 39:1-6
14. Jenkin D, Shabanah MA, Shail EA, Gray A, Hassounah M, Khafaga Y, Kofide A, Mustafa M, Schultz H (2000) Prognostic factors for medulloblastoma. Int J Radiat Oncol Biol Phys 47:573-584 (Pubitemid 30317473)
15. Evans AE, Jenkin RD, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin SL (1990) The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72:572-582 (Pubitemid 20113683)
16. Grabenbauer GG, Beck JD, Erhardt J, Seegenschmiedt MH, Seyer H, Thierauf P, Sauer R (1996) Postoperative radiotherapy of medulloblastoma. Impact of radiation quality on treatment outcome. Am J Clin Oncol 19:73-77 (Pubitemid 26037677)
17. Karlsson U, Kirby T, Orrison W, Lionberger M (1995) Ocular globe topography in radiotherapy. Int J Radiat Oncol Biol Phys 33:705-712
18. Miralbell R, Bleher A, Huguenin P, Ries G, Kann R, Mirimanoff RO, Notter M, Nouet P, Bieri S, Thum P, Toussi H (1997) Pediatric medulloblastoma: radiation treatment technique and patterns of failure. Int J Radiat Oncol Biol Phys 37:523-529 (Pubitemid 27175305)
19. Halperin EC (1996) Impact of radiation technique upon the outcome of treatment for medulloblastoma. Int J Radiat Oncol Biol Phys 36:233-239
20. Hardy DG, Hope-Stone HF, McKenzie CG, Scholtz CL (1978) Recurrence of medulloblastoma after homogeneous field radiotherapy. Report of three cases. J Neurosurg 49:434-440 (Pubitemid 9013327)
21. Carrie C, Hofstetter S, Gomez F, Moncho V, Doz F, Alapetite C, Murraciole X, Maire JP, Benhassel M, Chapet S, Quentin P, Kolodie H, Lagrange JL, Cuillere JC, Habrand JL (1999) Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys 45:435-439 (Pubitemid 29408560)
22. Carrie C, Muracciole X, Gomez F, Habrand J-L, Benhassel M, Mege M, Mahe M, Quetin P, Maire JP, Soum F, Baron MH, Clavere P, Chapet S, Gaci Z, Kolodie H, Maingon P, Vie B, Bernier V, Alapetite C, Hoffstetter S, Grill J, Lafay F (2005) Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol. Int J Radiat Oncol Biol Phys 63:711-716 (Pubitemid 41400056)
23. Sun L-M, Yeh S-A, Wang C-J, Huang E-Y, Chen H-C, Hsu H-C, Lee SP (2002) Postoperative radiation therapy for medulloblastoma - high recurrence rate in the subfrontal region. J Neurooncol 58:77-85 (Pubitemid 34711974)
24. Taylor RE, Bailey CC, Robinson KJ, Weston CL, Ellison D, Ironside J, Lucraft H, Gilbertson R, Tait DM, Saran F, Walker DA, Pizer BL, Lashford LS (2004) Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma. Int J Radiat Oncol Biol Phys 58:1184-1193 (Pubitemid 38314804)